Earnings PerformanceAlignment Healthcare reported solid fourth quarter results, with revenue rising 51% year-over-year and exceeding guidance and consensus expectations.
Future Growth ProspectsThe company's 2025 guidance, including membership growth and adjusted EBITDA projections, exceeds investors' expectations.
Market PositioningAnalysts have raised the price target for ALHC from $13 to $17, indicating increased confidence in the company's future performance.